Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

EQS-News: CGM registers significant increase in issued e-prescriptions


EQS-News: CompuGroup Medical SE Co. KGaA / Key word(s): Miscellaneous
CGM registers significant increase in issued e-prescriptions

14.12.2023 / 10:09 CET/CEST
The issuer is solely responsible for the content of this announcement.


CGM registers significant increase in issued e-prescriptions

Koblenz. The digitization of the German healthcare system is gaining more momentum: Last week, 715,000 e-prescriptions were issued in the Ambulatory Information Systems of CompuGroup Medical (CGM) alone. This represents an increase of 45 percent compared to the previous week. In the two-month period to and including December 10, a total of 2.7 million e-prescriptions were issued via CGM's Ambulatory Information Systems. E-prescriptions are redeemed via electronic health card, gematik app, CGM's CLICKDOC mobile solution, or by printing the data matrix code. 

"The strong increase of e-prescriptions shows: The digitization of the German healthcare system is making significant progress. With electronic prescriptions, it is now reaching all patients. CompuGroup Medical is driving this development in many ways. We are currently working intensively to support practice teams in introducing e-prescriptions and setting up convenient signature procedures. We offer a wide range of consulting services for new processes in the interaction between practices and software. Our core understanding is to be a partner at the physician's side," says Dr. Ulrich Thomé, Managing Director Ambulatory Information Systems DACH at CGM.

Dr. Beatrice Staudt, general practitioner and CGM user from Berlin, comments on the electronic prescription as follows: "Electronic prescribing significantly accelerates practice processes. It leads to greater safety in patient care. It takes the pressure off my practice team and our patients. I am pleased that digitization is advancing in the healthcare sector. The electronic doctor's letter and video consultation have also proved to be particularly helpful in my practice."

According to gematik, a total of 13.3 million e-prescriptions have now been issued in Germany. The number has more than doubled in the last two months. The amount of medical facilities that issue e-prescriptions on a weekly basis has also more than doubled and currently stands at 35,000. 17,300 - almost all - pharmacies accepted e-prescriptions last week.



14.12.2023 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: CompuGroup Medical SE Co. KGaA
Maria Trost 21
56070 Koblenz
Germany
Phone: +49 (0)160 3630362
Fax: +49 (0)261 8000 3200
E-mail: [email protected]
Internet: www.cgm.com
ISIN: DE000A288904
WKN: A28890
Indices: SDAX, TecDAX
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange
EQS News ID: 1796915

 
End of News EQS News Service

1796915  14.12.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1796915&application_name=news&site_id=sharewise

CompuGroup Medical SE & Co. KGaA Stock

€28.80
1.340%
There is an upward development for CompuGroup Medical SE & Co. KGaA compared to yesterday, with an increase of €0.38 (1.340%).

Like: 0
Share
EQS Group is a leading international provider of regulatory technology in the fields of corporate compliance and investor relations. In working with EQS Group, thousands of companies worldwide inspire trust by fulfilling complex national and international disclosure obligations, minimizing risks and communicating transparently with stakeholders.




Legal notice

Comments